메뉴 건너뛰기




Volumn 82, Issue , 2014, Pages 331-341

Viral vectors in primate research: Examples from Parkinson’s disease research

Author keywords

Central nervous system; Gene therapies; Gene transfer; Nonhuman primate; Parkinson s disease; Viral vectors

Indexed keywords

LENTIVIRUS VECTOR; PARVOVIRUS VECTOR;

EID: 84901836790     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-62703-610-8_17     Document Type: Article
Times cited : (2)

References (84)
  • 1
    • 79959345818 scopus 로고    scopus 로고
    • New animal models of Parkinson's disease
    • Dehay B, Bezard E (2011) New animal models of Parkinson's disease. Mov Disord 26(7):1198-1205
    • (2011) Mov Disord , vol.26 , Issue.7 , pp. 1198-1205
    • Dehay, B.1    Bezard, E.2
  • 2
    • 34249941829 scopus 로고    scopus 로고
    • Nerve growth factor gene therapy in Alzheimer disease
    • Tuszynski MH (2007) Nerve growth factor gene therapy in Alzheimer disease. Alzheimer Dis Assoc Disord 21(2):179-189
    • (2007) Alzheimer Dis Assoc Disord , vol.21 , Issue.2 , pp. 179-189
    • Tuszynski, M.H.1
  • 3
    • 84868611681 scopus 로고    scopus 로고
    • PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking
    • Porras G et al (2012) PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking. J Clin Invest 122(11): 3977-3989
    • (2012) J Clin Invest , vol.122 , Issue.11 , pp. 3977-3989
    • Porras, G.1
  • 4
    • 77952964676 scopus 로고    scopus 로고
    • Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease
    • Ahmed MR et al (2010) Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med 2(28):28ra28
    • (2010) Sci Transl Med , vol.2 , Issue.28
    • Ahmed, M.R.1
  • 5
    • 79955622718 scopus 로고    scopus 로고
    • Priorities in Parkinson's disease research
    • Meissner WG et al (2011) Priorities in Parkinson's disease research. Nat Rev Drug Discov 10(5):377-393
    • (2011) Nat Rev Drug Discov , vol.10 , Issue.5 , pp. 377-393
    • Meissner, W.G.1
  • 6
    • 21044458854 scopus 로고    scopus 로고
    • A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease
    • Tuszynski MH et al (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11(5):551-555
    • (2005) Nat Med , vol.11 , Issue.5 , pp. 551-555
    • Tuszynski, M.H.1
  • 7
    • 78349247631 scopus 로고    scopus 로고
    • Gene delivery of AAV2-neurturin for Parkinson's disease: A double-blind, randomised, controlled trial
    • Marks WJ Jr et al (2010) Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 9(12):1164-1172
    • (2010) Lancet Neurol , vol.9 , Issue.12 , pp. 1164-1172
    • Marks, W.J.1
  • 8
    • 60649116702 scopus 로고    scopus 로고
    • Applications of lentiviral vectors for biology and gene therapy of neurological disorders
    • Lundberg C et al (2008) Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther 8(6):461-473
    • (2008) Curr Gene Ther , vol.8 , Issue.6 , pp. 461-473
    • Lundberg, C.1
  • 9
    • 0032752994 scopus 로고    scopus 로고
    • Lentiviral gene transfer to the nonhuman primate brain
    • Kordower JH et al (1999) Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160(1):1-16
    • (1999) Exp Neurol , vol.160 , Issue.1 , pp. 1-16
    • Kordower, J.H.1
  • 10
    • 0037378036 scopus 로고    scopus 로고
    • In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease
    • discussion S132-4
    • Kordower JH (2003) In vivo gene delivery of glial cell line-derived neurotrophic factor for Parkinson's disease. Ann Neurol 53(Suppl 3):S120-S132, discussion S132-4
    • (2003) Ann Neurol , vol.53 , pp. 120-132
    • Kordower, J.H.1
  • 11
    • 77956747059 scopus 로고    scopus 로고
    • Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates
    • Gash DM, Gerhardt GA, Hoffer BJ (1998) Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates. Adv Pharmacol 42:911-915
    • (1998) Adv Pharmacol , vol.42 , pp. 911-915
    • Gash, D.M.1    Gerhardt, G.A.2    Hoffer, B.J.3
  • 12
    • 0034721690 scopus 로고    scopus 로고
    • Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
    • Kordower JH et al (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290(5492):767-773
    • (2000) Science , vol.290 , Issue.5492 , pp. 767-773
    • Kordower, J.H.1
  • 13
    • 0037096359 scopus 로고    scopus 로고
    • Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration
    • Palfi S et al (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J Neurosci 22(12):4942-4954
    • (2002) J Neurosci , vol.22 , Issue.12 , pp. 4942-4954
    • Palfi, S.1
  • 14
    • 76949085430 scopus 로고    scopus 로고
    • Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia
    • Jarraya B et al (2009) Dopamine gene therapy for Parkinson's disease in a nonhuman primate without associated dyskinesia. Sci Transl Med 1(2):2ra4
    • (2009) Sci Transl Med , vol.1 , Issue.2
    • Jarraya, B.1
  • 15
    • 0035434121 scopus 로고    scopus 로고
    • Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
    • Bezard E, Brotchie JM, Gross CE (2001) Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci 2(8):577-588
    • (2001) Nat Rev Neurosci , vol.2 , Issue.8 , pp. 577-588
    • Bezard, E.1    Brotchie, J.M.2    Gross, C.E.3
  • 16
    • 34248575534 scopus 로고    scopus 로고
    • Levodopa in the treatment of Parkinson's disease
    • Fahn S (2006) Levodopa in the treatment of Parkinson's disease. J Neural Transm Suppl (71):1-15
    • (2006) J Neural Transm Suppl , Issue.71 , pp. 1-15
    • Fahn, S.1
  • 17
    • 34147170029 scopus 로고    scopus 로고
    • Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates
    • Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E (2007) Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates. Neurobiol Dis 26(2):452-463
    • (2007) Neurobiol Dis , vol.26 , Issue.2 , pp. 452-463
    • Guigoni, C.1    Doudnikoff, E.2    Li, Q.3    Bloch, B.4    Bezard, E.5
  • 18
    • 15944407993 scopus 로고    scopus 로고
    • L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain
    • Bezard E et al (2005) L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain. Neurobiol Dis 18(2): 323-335
    • (2005) Neurobiol Dis , vol.18 , Issue.2 , pp. 323-335
    • Bezard, E.1
  • 19
    • 78650753240 scopus 로고    scopus 로고
    • Inhibition of Rasguanine nucleotide-releasing factor 1 (Ras- GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia
    • Fasano S et al (2010) Inhibition of Rasguanine nucleotide-releasing factor 1 (Ras- GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia. Proc Natl Acad Sci USA 107(50):21824-21829
    • (2010) Proc Natl Acad Sci USA , vol.107 , Issue.50 , pp. 21824-21829
    • Fasano, S.1
  • 20
    • 0029417121 scopus 로고
    • Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus)
    • Pearce RK, Jackson M, Smith L, Jenner P, Marsden CD (1995) Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus). Mov Disord 10(6):731-740
    • (1995) Mov Disord , vol.10 , Issue.6 , pp. 731-740
    • Pearce, R.K.1    Jackson, M.2    Smith, L.3    Jenner, P.4    Marsden, C.D.5
  • 21
    • 37549025843 scopus 로고    scopus 로고
    • RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease
    • Gold SJ et al (2007) RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. J Neurosci 27(52):14338-14348
    • (2007) J Neurosci , vol.27 , Issue.52 , pp. 14338-14348
    • Gold, S.J.1
  • 22
    • 16344390018 scopus 로고    scopus 로고
    • Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia
    • Nash JE, Johnston TH, Collingridge GL, Garner CC, Brotchie JM (2005) Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson's disease and L-DOPA-induced dyskinesia. FASEB J 19(6):583-585
    • (2005) FASEB J , vol.19 , Issue.6 , pp. 583-585
    • Nash, J.E.1    Johnston, T.H.2    Collingridge, G.L.3    Garner, C.C.4    Brotchie, J.M.5
  • 23
    • 34547136437 scopus 로고    scopus 로고
    • Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non- human primates
    • Palfi S et al (2007) Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non- human primates. Mol Ther 15(8): 1444-1451
    • (2007) Mol Ther , vol.15 , Issue.8 , pp. 1444-1451
    • Palfi, S.1
  • 24
    • 40549119871 scopus 로고    scopus 로고
    • Designer gene delivery vectors: Molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer
    • Kwon I, Schaffer DV (2008) Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res 25(3): 489-499
    • (2008) Pharm Res , vol.25 , Issue.3 , pp. 489-499
    • Kwon, I.1    Schaffer, D.V.2
  • 25
    • 70249151690 scopus 로고    scopus 로고
    • Adenovirus-adeno-associated virus hybrid for large-scale recombinant adenoassociated virus production
    • Zhang H, Xie J, Xie Q, Wilson JM, Gao G (2009) Adenovirus-adeno-associated virus hybrid for large-scale recombinant adenoassociated virus production. Hum Gene Ther 20(9):922-929
    • (2009) Hum Gene Ther , vol.20 , Issue.9 , pp. 922-929
    • Zhang, H.1    Xie, J.2    Xie, Q.3    Wilson, J.M.4    Gao, G.5
  • 26
  • 27
    • 0037015049 scopus 로고    scopus 로고
    • Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
    • Gao GP et al (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99(18):11854-11859
    • (2002) Proc Natl Acad Sci USA , vol.99 , Issue.18 , pp. 11854-11859
    • Gao, G.P.1
  • 28
    • 62549159967 scopus 로고    scopus 로고
    • Tailoring the AAV vector capsid for gene therapy
    • Vandenberghe LH, Wilson JM, Gao G (2009) Tailoring the AAV vector capsid for gene therapy. Gene Ther 16(3):311-319
    • (2009) Gene Ther , vol.16 , Issue.3 , pp. 311-319
    • Vandenberghe, L.H.1    Wilson, J.M.2    Gao, G.3
  • 29
    • 0033942230 scopus 로고    scopus 로고
    • Convectionenhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach
    • Bankiewicz KS et al (2000) Convectionenhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol 164(1):2-14
    • (2000) Exp Neurol , vol.164 , Issue.1 , pp. 2-14
    • Bankiewicz, K.S.1
  • 30
    • 33748083041 scopus 로고    scopus 로고
    • Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC
    • Bankiewicz KS et al (2006) Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther 14(4):564-570
    • (2006) Mol Ther , vol.14 , Issue.4 , pp. 564-570
    • Bankiewicz, K.S.1
  • 31
    • 33748074480 scopus 로고    scopus 로고
    • A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys
    • Forsayeth JR et al (2006) A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys. Mol Ther 14(4):571-577
    • (2006) Mol Ther , vol.14 , Issue.4 , pp. 571-577
    • Forsayeth, J.R.1
  • 32
    • 77955175906 scopus 로고    scopus 로고
    • Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC
    • Hadaczek P et al (2010) Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC. Mol Ther 18(8):1458-1461
    • (2010) Mol Ther , vol.18 , Issue.8 , pp. 1458-1461
    • Hadaczek, P.1
  • 33
    • 0036210202 scopus 로고    scopus 로고
    • Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adenoassociated viral vectors expressing dopaminesynthesizing enzymes
    • Muramatsu S et al (2002) Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adenoassociated viral vectors expressing dopaminesynthesizing enzymes. Hum Gene Ther 13(3):345-354
    • (2002) Hum Gene Ther , vol.13 , Issue.3 , pp. 345-354
    • Muramatsu, S.1
  • 34
    • 0011087583 scopus 로고    scopus 로고
    • Deep brain stimulation for Parkinson's disease: Disrupting the disruption
    • Lozano AM, Dostrovsky J, Chen R, Ashby P (2002) Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol 1(4):225-231
    • (2002) Lancet Neurol , vol.1 , Issue.4 , pp. 225-231
    • Lozano, A.M.1    Dostrovsky, J.2    Chen, R.3    Ashby, P.4
  • 35
    • 33847198228 scopus 로고    scopus 로고
    • Subthalamic glutamic acid decarboxylase gene therapy: Changes in motor function and cortical metabolism
    • Emborg ME et al (2007) Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab 27(3):501-509
    • (2007) J Cereb Blood Flow Metab , vol.27 , Issue.3 , pp. 501-509
    • Emborg, M.E.1
  • 36
    • 37349011012 scopus 로고    scopus 로고
    • Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease
    • Feigin A et al (2007) Modulation of metabolic brain networks after subthalamic gene therapy for Parkinson's disease. Proc Natl Acad Sci USA 104(49):19559-19564
    • (2007) Proc Natl Acad Sci USA , vol.104 , Issue.49 , pp. 19559-19564
    • Feigin, A.1
  • 37
    • 79952740079 scopus 로고    scopus 로고
    • AAV2-GAD gene therapy for advanced Parkinson's disease: A doubleblind, sham-surgery controlled, randomised trial
    • LeWitt PA et al (2011) AAV2-GAD gene therapy for advanced Parkinson's disease: a doubleblind, sham-surgery controlled, randomised trial. Lancet Neurol 10(4):309-319
    • (2011) Lancet Neurol , vol.10 , Issue.4 , pp. 309-319
    • LeWitt, P.A.1
  • 38
    • 12844287442 scopus 로고    scopus 로고
    • Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease
    • Eslamboli A et al (2005) Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J Neurosci 25(4):769-777
    • (2005) J Neurosci , vol.25 , Issue.4 , pp. 769-777
    • Eslamboli, A.1
  • 39
    • 77954692657 scopus 로고    scopus 로고
    • Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2- GDNF
    • Kells AP et al (2010) Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2- GDNF. J Neurosci 30(28):9567-9577
    • (2010) J Neurosci , vol.30 , Issue.28 , pp. 9567-9577
    • Kells, A.P.1
  • 40
    • 33845993229 scopus 로고    scopus 로고
    • Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTPtreated monkeys
    • Kordower JH et al (2006) Delivery of neurturin by AAV2 (CERE-120)-mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTPtreated monkeys. Ann Neurol 60(6):706-715
    • (2006) Ann Neurol , vol.60 , Issue.6 , pp. 706-715
    • Kordower, J.H.1
  • 41
    • 68949175520 scopus 로고    scopus 로고
    • Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease
    • Berton O et al (2009) Striatal overexpression of DeltaJunD resets L-DOPA-induced dyskinesia in a primate model of Parkinson disease. Biol Psychiatry 66(6):554-561
    • (2009) Biol Psychiatry , vol.66 , Issue.6 , pp. 554-561
    • Berton, O.1
  • 42
    • 64049083111 scopus 로고    scopus 로고
    • Human alpha- iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: Vector diffusion and biodistribution
    • Ciron C et al (2009) Human alpha- iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution. Hum Gene Ther 20(4):350-360
    • (2009) Hum Gene Ther , vol.20 , Issue.4 , pp. 350-360
    • Ciron, C.1
  • 43
    • 64149106830 scopus 로고    scopus 로고
    • Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system
    • McFarland NR, Lee JS, Hyman BT, McLean PJ (2009) Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system. J Neurochem 109(3):838-845
    • (2009) J Neurochem , vol.109 , Issue.3 , pp. 838-845
    • McFarland, N.R.1    Lee, J.S.2    Hyman, B.T.3    McLean, P.J.4
  • 44
    • 34247271439 scopus 로고    scopus 로고
    • Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain
    • Taymans JM et al (2007) Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 18(3):195-206
    • (2007) Hum Gene Ther , vol.18 , Issue.3 , pp. 195-206
    • Taymans, J.M.1
  • 45
    • 77649331498 scopus 로고    scopus 로고
    • Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate
    • Colle MA et al (2010) Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primate. Hum Mol Genet 19(1):147-158
    • (2010) Hum Mol Genet , vol.19 , Issue.1 , pp. 147-158
    • Colle, M.A.1
  • 46
    • 77649270699 scopus 로고    scopus 로고
    • Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates
    • Dodiya HB et al (2010) Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates. Mol Ther 18(3):579-587
    • (2010) Mol Ther , vol.18 , Issue.3 , pp. 579-587
    • Dodiya, H.B.1
  • 47
    • 62549094869 scopus 로고    scopus 로고
    • Transduction of nonhuman primate brain with adeno-associated virus serotype 1: Vector trafficking and immune response
    • Hadaczek P et al (2009) Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum Gene Ther 20(3):225-237
    • (2009) Hum Gene Ther , vol.20 , Issue.3 , pp. 225-237
    • Hadaczek, P.1
  • 48
    • 77649271981 scopus 로고    scopus 로고
    • Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain
    • Markakis EA et al (2010) Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain. Mol Ther 18(3):588-593
    • (2010) Mol Ther , vol.18 , Issue.3 , pp. 588-593
    • Markakis, E.A.1
  • 49
    • 79952258871 scopus 로고    scopus 로고
    • Recombinant adenoassociated virus type 2 pseudotypes: Comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation
    • Sanchez CE et al (2011) Recombinant adenoassociated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation. J Neurosurg 114(3):672-680
    • (2011) J Neurosurg , vol.114 , Issue.3 , pp. 672-680
    • Sanchez, C.E.1
  • 50
    • 33845196246 scopus 로고    scopus 로고
    • Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates
    • Yasuda T et al (2007) Neuronal specificity of alpha-synuclein toxicity and effect of Parkin co-expression in primates. Neuroscience 144(2):743-753
    • (2007) Neuroscience , vol.144 , Issue.2 , pp. 743-753
    • Yasuda, T.1
  • 51
    • 35148872604 scopus 로고    scopus 로고
    • DNA palindromes with a modest arm length of greater, similar 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice
    • Inagaki K et al (2007) DNA palindromes with a modest arm length of greater, similar 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice. J Virol 81(20):11290-11303
    • (2007) J Virol , vol.81 , Issue.20 , pp. 11290-11303
    • Inagaki, K.1
  • 52
    • 79961032418 scopus 로고    scopus 로고
    • Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system
    • Zhang H et al (2011) Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol Ther 19(8):1440-1448
    • (2011) Mol Ther , vol.19 , Issue.8 , pp. 1440-1448
    • Zhang, H.1
  • 53
    • 60149106907 scopus 로고    scopus 로고
    • Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
    • Foust KD et al (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27(1):59-65
    • (2009) Nat Biotechnol , vol.27 , Issue.1 , pp. 59-65
    • Foust, K.D.1
  • 54
    • 67649861393 scopus 로고    scopus 로고
    • Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons
    • Duque S et al (2009) Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther 17(7):1187-1196
    • (2009) Mol Ther , vol.17 , Issue.7 , pp. 1187-1196
    • Duque, S.1
  • 55
    • 78751700314 scopus 로고    scopus 로고
    • Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
    • Dominguez E et al (2011) Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Hum Mol Genet 20(4):681-693
    • (2011) Hum Mol Genet , vol.20 , Issue.4 , pp. 681-693
    • Dominguez, E.1
  • 56
    • 77749249680 scopus 로고    scopus 로고
    • Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
    • Foust KD et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28(3):271-274
    • (2010) Nat Biotechnol , vol.28 , Issue.3 , pp. 271-274
    • Foust, K.D.1
  • 57
    • 79955574241 scopus 로고    scopus 로고
    • Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder
    • Spampanato C et al (2011) Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder. Mol Ther 19(5):860-869
    • (2011) Mol Ther , vol.19 , Issue.5 , pp. 860-869
    • Spampanato, C.1
  • 58
    • 79957888016 scopus 로고    scopus 로고
    • Preclinical differences of intravascular AAV9 delivery to neurons and glia: A comparative study of adult mice and nonhuman primates
    • Gray SJ et al (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19(6):1058-1069
    • (2011) Mol Ther , vol.19 , Issue.6 , pp. 1058-1069
    • Gray, S.J.1
  • 59
    • 80455173951 scopus 로고    scopus 로고
    • Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders
    • Bevan AK et al (2011) Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther 19(11):1971-1980
    • (2011) Mol Ther , vol.19 , Issue.11 , pp. 1971-1980
    • Bevan, A.K.1
  • 60
    • 84860171925 scopus 로고    scopus 로고
    • Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates
    • Samaranch L et al (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23(4):382-389
    • (2012) Hum Gene Ther , vol.23 , Issue.4 , pp. 382-389
    • Samaranch, L.1
  • 61
    • 84859743388 scopus 로고    scopus 로고
    • Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques
    • Dehay B, Dalkara D, Dovero S, Li Q, Bezard E (2012) Systemic scAAV9 variant mediates brain transduction in newborn rhesus macaques. Sci Rep 2:253
    • (2012) Sci Rep , vol.2 , pp. 253
    • Dehay, B.1    Dalkara, D.2    Dovero, S.3    Li, Q.4    Bezard, E.5
  • 62
    • 84871994994 scopus 로고    scopus 로고
    • Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems
    • Mattar CN et al (2013) Systemic delivery of scAAV9 in fetal macaques facilitates neuronal transduction of the central and peripheral nervous systems. Gene Ther 20(1):69-83
    • (2013) Gene Ther , vol.20 , Issue.1 , pp. 69-83
    • Mattar, C.N.1
  • 63
    • 84864877570 scopus 로고    scopus 로고
    • Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs
    • Federici T et al (2012) Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther 19(8):852-859
    • (2012) Gene Ther , vol.19 , Issue.8 , pp. 852-859
    • Federici, T.1
  • 64
    • 79952193362 scopus 로고    scopus 로고
    • MicroRNA-regulated, systemically delivered rAAV9: A step closer to CNS-restricted transgene expression
    • Xie J et al (2011) MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression. Mol Ther 19(3):526-535
    • (2011) Mol Ther , vol.19 , Issue.3 , pp. 526-535
    • Xie, J.1
  • 65
    • 84859440283 scopus 로고    scopus 로고
    • The AAV vector toolkit: Poised at the clinical crossroads
    • Asokan A, Schaffer DV, Samulski RJ (2012) The AAV vector toolkit: poised at the clinical crossroads. Mol Ther 20(4):699-708
    • (2012) Mol Ther , vol.20 , Issue.4 , pp. 699-708
    • Asokan, A.1    Schaffer, D.V.2    Samulski, R.J.3
  • 66
    • 77649273563 scopus 로고    scopus 로고
    • Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB)
    • Gray SJ et al (2010) Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol Ther 18(3):570-578
    • (2010) Mol Ther , vol.18 , Issue.3 , pp. 570-578
    • Gray, S.J.1
  • 67
    • 74049120342 scopus 로고    scopus 로고
    • Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle
    • Asokan A et al (2010) Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle. Nat Biotechnol 28(1):79-82
    • (2010) Nat Biotechnol , vol.28 , Issue.1 , pp. 79-82
    • Asokan, A.1
  • 68
    • 84875925195 scopus 로고    scopus 로고
    • Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates
    • Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Jude Samulski R (2013) Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther 20(4):450-459
    • (2013) Gene Ther , vol.20 , Issue.4 , pp. 450-459
    • Gray, S.J.1    Nagabhushan Kalburgi, S.2    McCown, T.J.3    Jude Samulski, R.4
  • 69
    • 78649325447 scopus 로고    scopus 로고
    • Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII
    • Bielicki J, McIntyre C, Anson DS (2010) Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII. Mol Genet Metab 101(4):370-382
    • (2010) Mol Genet Metab , vol.101 , Issue.4 , pp. 370-382
    • Bielicki, J.1    McIntyre, C.2    Anson, D.S.3
  • 70
    • 0038618702 scopus 로고    scopus 로고
    • Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidasedeficient mice
    • Passini MA et al (2003) Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidasedeficient mice. J Virol 77(12):7034-7040
    • (2003) J Virol , vol.77 , Issue.12 , pp. 7034-7040
    • Passini, M.A.1
  • 72
    • 79961013057 scopus 로고    scopus 로고
    • Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease
    • Lam MF, Thomas MG, Lind CR (2011) Neurosurgical convection-enhanced delivery of treatments for Parkinson's disease. J Clin Neurosci 18(9):1163-1167
    • (2011) J Clin Neurosci , vol.18 , Issue.9 , pp. 1163-1167
    • Lam, M.F.1    Thomas, M.G.2    Lind, C.R.3
  • 73
    • 23444437213 scopus 로고
    • Convection-enhanced delivery of macromolecules in the brain
    • Bobo RH et al (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91(6):2076-2080
    • (1994) Proc Natl Acad Sci USA , vol.91 , Issue.6 , pp. 2076-2080
    • Bobo, R.H.1
  • 74
    • 45749146197 scopus 로고    scopus 로고
    • Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain
    • Cunningham J et al (2008) Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain. Mol Ther 16(7):1267-1275
    • (2008) Mol Ther , vol.16 , Issue.7 , pp. 1267-1275
    • Cunningham, J.1
  • 75
    • 37349081554 scopus 로고    scopus 로고
    • Image-guided convection- enhanced delivery platform in the treatment of neurological diseases
    • Fiandaca MS, Forsayeth JR, Dickinson PJ, Bankiewicz KS (2008) Image-guided convection- enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics 5(1):123-127
    • (2008) Neurotherapeutics , vol.5 , Issue.1 , pp. 123-127
    • Fiandaca, M.S.1    Forsayeth, J.R.2    Dickinson, P.J.3    Bankiewicz, K.S.4
  • 77
    • 3242747428 scopus 로고    scopus 로고
    • A realistic brain tissue phantom for intraparenchymal infusion studies
    • Chen ZJ et al (2004) A realistic brain tissue phantom for intraparenchymal infusion studies. J Neurosurg 101(2):314-322
    • (2004) J Neurosurg , vol.101 , Issue.2 , pp. 314-322
    • Chen, Z.J.1
  • 78
    • 33747614013 scopus 로고    scopus 로고
    • In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle
    • Fatouros PP et al (2006) In vitro and in vivo imaging studies of a new endohedral metallofullerene nanoparticle. Radiology 240(3):756-764
    • (2006) Radiology , vol.240 , Issue.3 , pp. 756-764
    • Fatouros, P.P.1
  • 79
    • 32044440778 scopus 로고    scopus 로고
    • Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents
    • Krauze MT et al (2005) Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 103(5): 923-929
    • (2005) J Neurosurg , vol.103 , Issue.5 , pp. 923-929
    • Krauze, M.T.1
  • 80
    • 79951557738 scopus 로고    scopus 로고
    • Design of an indwelling cannula for convection-enhanced delivery
    • Rosenbluth KH et al (2011) Design of an indwelling cannula for convection-enhanced delivery. J Neurosci Methods 196(1):118-123
    • (2011) J Neurosci Methods , vol.196 , Issue.1 , pp. 118-123
    • Rosenbluth, K.H.1
  • 81
    • 22044450632 scopus 로고    scopus 로고
    • AAV2-mediated gene delivery to monkey putamen: Evaluation of an infusion device and delivery parameters
    • Sanftner LM et al (2005) AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters. Exp Neurol 194(2):476-483
    • (2005) Exp Neurol , vol.194 , Issue.2 , pp. 476-483
    • Sanftner, L.M.1
  • 82
    • 27744517790 scopus 로고    scopus 로고
    • Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain
    • Saito R et al (2005) Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol 196(2):381-389
    • (2005) Exp Neurol , vol.196 , Issue.2 , pp. 381-389
    • Saito, R.1
  • 83
    • 78650813431 scopus 로고    scopus 로고
    • Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and nonhuman primates
    • Yin D et al (2011) Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and nonhuman primates. Neuroimage 54(Suppl 1):S196-S203
    • (2011) Neuroimage , vol.54 , pp. 196-203
    • Yin, D.1
  • 84
    • 44949222522 scopus 로고    scopus 로고
    • Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
    • Eberling JL et al (2008) Results from a phase I safety trial of hAADC gene therapy for Parkinson disease. Neurology 70(21):1980-1983
    • (2008) Neurology , vol.70 , Issue.21 , pp. 1980-1983
    • Eberling, J.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.